Literature DB >> 23393440

Creating therapeutic proteins from bioengineered systems.

Richard V McCloskey1.   

Abstract

If scientific and social obstacles can be overcome, the use of plants and animals as living production facilities to effect protein expression could be the key to reducing R&D costs - and ultimately, the cost of therapies that will benefit millions of people.

Entities:  

Year:  2004        PMID: 23393440      PMCID: PMC3564303     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN: 1554-169X


  2 in total

1.  Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures.

Authors:  J M Sharp; P M Doran
Journal:  Biotechnol Prog       Date:  2001 Nov-Dec

2.  High-yield production of a human therapeutic protein in tobacco chloroplasts.

Authors:  J M Staub; B Garcia; J Graves; P T Hajdukiewicz; P Hunter; N Nehra; V Paradkar; M Schlittler; J A Carroll; L Spatola; D Ward; G Ye; D A Russell
Journal:  Nat Biotechnol       Date:  2000-03       Impact factor: 54.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.